To win the war on cancer, we must recapture the bold spirit of the early days of discovery.
The first attempt to treat cancer in humans with chemotherapy happened within days of doctors realizing that it reduced the size of tumors in mice.
The year was 1942, and we were at war. Yale pharmacologist Alfred Gilman was serving as chief of the pharmacology section in the Army Medical Division at Edgewood Arsenal, Maryland, working on developing antidotes to nerve gases and other chemical weapons the Army feared would be used against American troops.
After a few months of researching mustard gas in mice, Gilman and his collaborator, Louis S. Goodman, noticed that the poison also caused a regression of cancer in the rodents. Just a few days later, they persuaded a professor of surgery at Yale to run a clinical trial on a patient with terminal cancer; within 48 hours, the patient’s tumors had receded.
In 1971, three decades after Gilman’s discovery, the U.S. government declared a “war on cancer.” Since then, we have spent nearly $200 billion in federal money on research to defeat the disease. But we haven’t gotten much bang for our buck: Cancer deaths have fallen by a total of just 5 percent since 1950. (In comparison, heart disease deaths are a third of what they were then, thanks to innovations like statins, stents, and bypass surgery.) The American Cancer Society estimates that more than 600,000 Americans die of cancer annually; 33 percent of those diagnosed will be dead within five years.
This story is from the June 2018 edition of Reason magazine.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the June 2018 edition of Reason magazine.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
'Smoking Opium Is Not Our Vice'
America’s first drug war was driven by xenophobia against chinese migrants.
THE LIBERTARIAN MIND OF DAVID BOAZ
Threats to freedom, Trump vs. Biden, and the wins libertarians can’t seem to acknowledge
DARE TO Fail
THERE’S NO SUCH thing as a universal millennial experience, but DARE comes close.
CULTURE WARRIOR IN CHIEF
THE MODERN PRESIDENCY IS A DIVIDER, NOT A UNITER. IT HAS BECOME FAR TOO POWERFUL TO BE ANYTHING ELSE.
Progress, Rediscovered
A NEW MOVEMENT PROMOTING SCIENTIFIC, TECHNOLOGICAL, AND ECONOMIC SOLUTIONS TO HUMANITY’S PROBLEMS EMERGES.
HOW CAPITALISM BEAT COMMUNISM IN VIETNAM
IT ONLY TOOK A GENERATION TO GO FROM RATION CARDS TO EXPORTING ELECTRONICS.
50 Years of D&D: You Can't Copyright Fun
THIS YEAR MARKS the 50th anniversary of the original edition of Dungeons & Dragons (D&D), the granddaddy of tabletop role-playing games and one of the urtexts of nerd culture.
The Pupil Panopticon
BIG BROTHER—and Parent, and Teacher— are watching.
Congress Could Swipe Your Credit Reward Points
A PLOT TO kill credit card reward points has bipartisan buy-in, with lawmakers framing the effort as an attempt to curb stillstubborn inflation.
Regulators Killed a Lifeline for Roombas
IN JANUARY 2024, Amazon terminated its agreement to acquire iRobot, the company that manufactures the Roomba robot vacuum.